Biomedical subjects

S Kahl

Publications and source records attributed to S Kahl.

At least 73 records · Page 4Linked to original sources

PubMed1997

Argon plasma coagulation (APC) in gastroenterology: experimental and clinical experiences.

BACKGROUND: Diathermy procedures are indispensable in interventional endoscopy. Argon beam coagulation is an innovative no-touch electrocoagulation technique in which high-frequency alternating current is delivered to the tissue through ionized argon gas. METHOD AND PATIENTS: Before clinical application, we conducted in-vitro studies to investigate the depth and diameters of tissue coagulation in fresh operative specimens from the stomach, small intestine and colon. Five different power/gas flow settings between 40 and 155 W and 2 and 7 l/min were used. The impact time (1-10s) and the incident angle of the probe (45 degrees and 90 degrees) were also varied. The maximum depth of necrosis was 2.4 mm, the maximum diameter 1.1 cm. No perforation occurred even in critical areas such as the colon and duodenum. We therefore performed argon beam coagulation in 66 consecutive patients. Two power/gas flow settings of 40 and 70 W and 2 and 3 l/min, respectively, were used. The impact time and incident angle were varied individually. RESULTS: In 49 of the 50 patients with oozing haemorrhage from angiodysplastic lesions, polypectomy sites, erosions or ulcers or oozing of blood due to vascular penetration by tumours, definitive haemostasis was achieved in one to two sessions. In all 11 patients with residual sessile adenoma tissue, complete removal was possible. Oesophageal patency was restored in all five patients with stenosing tumours. In one patient with angiodysplasia of the caecal pole, an asymptomatic accumulation of gas in the submucosa was observed which resolved spontaneously. In two patients with extensive oesophageal carcinoma, there was a transitory--also asymptomatic--accumulation of gas in the mediastinum and peritoneal cavity but no evidence of perforation. CONCLUSION: Argon plasma electrocoagulation is an effective and relatively low-cost alternative to laser therapy in gastrointestinal endoscopy.

Adenoma↗

PubMed1997

Nutritional regulation of plasma tumor necrosis factor-alpha and plasma and urinary nitrite/nitrate responses to endotoxin in cattle.

Effects of dietary protein level with and without L-arginine (Arg) infusion on plasma tumor necrosis factor-alpha (TNF-alpha) response to endotoxin (lipopolysaccharide [LPS]) as well as plasma concentration and urine output of nitrite and nitrate (NOx), the stable end products of nitric oxide radical (NO), were studied in beef heifers (275-310 kg body wt). The animals were fed low- (LP; 7.96%) or high- (HP; 13.94%) protein diets for 10 days before LPS administration (Escherichia coli; 0.2 microgram/kg, iv). L-Arginine in saline (0.5 g/kg body wt) or saline was infused for 8 hr with one-third of total Arg infused before LPS administration. Plasma TNF-alpha concentrations increased in all heifers after LPS injection (peak at 1 hr and return to baseline at 4 hr); however, concentrations were lower in HP- than in LP-fed heifers at 1, 2, and 3 hr. Infusion of Arg did not affect plasma TNF-alpha response to LPS. Plasma NOx concentrations increased in all heifers after LPS challenge; compared with saline, Arg infusion increased the total response (integrated area under concentration curve) in LP- but not in HP-fed heifers. Relative to pretreatment period, the rate of NOx output in urine collected 2-6 hr after LPS administration increased in all heifers regardless of dietary protein level and was further amplified by Arg infusion. The rate of NOx output in urine collected 6-24 hr after LPS challenge was even higher in LP-fed heifers infused with Arg but returned to the basal values in other groups. Activity of hepatic inducible NO synthase was not affected by LPS, Arg, or dietary protein level at the time points studied. The data suggest that dietary protein levels can modulate both TNF-alpha and NO responses to LPS in cattle; high dietary protein intake decreases TNF-alpha response and attenuates the conversion of supplemental Arg to NO.

Animals↗

PubMed1996

Roasted soybeans and an estrogenic growth promoter affect growth hormone status and performance of beef steers.

This study investigated the effects of a roasted soybean (RSB)-supplemented diet and an estrogen implant (SYN; Synovex-S ear implant, 20 mg estradiol benzoate plus 200 mg progesterone) in young crossbred beef steers on their performance and plasma growth hormone (GH) response to challenge injections of thyrotropin-releasing hormone (TRH) + GH-releasing hormone (GHRH). Twenty individually fed steers (body weight 255 +/- 5 kg) were assigned to the following treatments: 1) no SYN and fed a soybean meal-supplemented diet, 2) no SYN and fed the RSB-supplemented diet, 3) plus SYN and soybean meal, and 4) plus SYN and RSB. Steers were fed 1.13 MJ metabolizable energy/kg metabolic body weight daily of an 18% protein diet. After a 5-wk growth period, all steers were challenged (intravenous injection) over a 3-wk period with three levels of a combination of TRH + GHRH (0.1 + 0.01, 1.0 + 0.1, 2.5 + 0.25 microg/kg body weight, respectively). After an additional 3 wk, steers were reimplanted and a second 5-wk growth period was followed by a single challenge of the 1.0 + 0.1 TRH + GHRH dose level. Plasma nonesterified fatty acid concentration was greater when steers were fed the RSB compared with soybean meal (265 vs. 205 micromol/L; P < 0.01; SEM = 9.5). Body weight gains for treatments 1, 2, 3 and 4 were 1.35, 1.21, 1.47 and 1.38 kg/d, respectively (RSB, P < 0.10; SYN, P < 0.07; SEM = 0.06). Gain/dry matter intake (g/kg) means were 184, 167, 197 and 184 (RSB, P< 0.04; SYN, P < 0.07; SEM = 7.5). Feeding roasted soybeans results in depressed area under the GH response curve [907, 555, 827 and 989 microg/(L*min) (SYN x RSB, P < 0.03; SEM = 117)] and depressed peak response (37.2, 26.6, 33.5 and 41.1 microg/L [SYN x RSB, P < 0.05; SEM = 4.5]), an effect alleviated by estrogen for young growing steers (Period 1) but not for heavier steers (Period 2).

Animals↗

PubMed1996

Effects of Synovex-S and recombinant bovine growth hormone (Somavubove) on growth responses of steers: I. Performance and composition of gain.

The influence of Synovex-S (SYN) ear implant (200 mg progesterone and 20 mg estradiol benzoate) and Somavubove (SbV) recombinant bovine growth hormone (.1 mg/kg BW i.m., daily) on live animal performance, tissue growth, and the partitioning of energy gain was determined using a slaughter-balance protocol with 25 young MARC II x (Angus-Hereford crossbred) beef steers (initial BW 182 +/- 1.8 kg). Following 21 d of adjustment to individual pens and to a diet of 80% concentrate and 20% corn-grass (1:1) silages, five groups of five steers per group were assigned to initial slaughter or a 2 x 2 factorial arrangement of treatments of CTL (no implant + daily placebo i.m. injection of bicarbonate-saline), SYN (implant + placebo), SbV, or SYN + SbV and slaughtered at 56 d on treatment. Steers were fed (per kilogram BW.75 daily) 20 g of CP and 252 Kcal of ME and consumed 5.5 +/- .07 kg/d DM across treatments. Empty body and carcass gains were affected (SYN, P < .01; SbV, P < .01) by treatments (CTL, SYN, SbV, and SYN + SbV: 1.26, 1.43, 1.63, 1.78 kg/d, SEM = .05, and .78, .97, .97, 1.08 kg/d, SEM = .04, respectively). Noncarcass gain was .45, .48, .60, and .60 kg/d (SEM = .03; SbV, P < .01). For empty body, both protein and water gains were greater for SYN-implanted steers (P < .05) than for steers not implanted and for SbV-injected steers (P < .01) than for placebo-injected steers. Treatments did not influence the efficiency of energy gain. The proportional amount of energy deposited as protein was greater (P < .01) for SbV-injected steers than for placebo-injected steers. The proportional amount of protein deposited was not influenced by SYN (P > .10); however, means were numerically greater for SYN-implanted steers than for steers not implanted, the largest mean being for the SYN + SbV treatment group. Somavubove increased (P < .01) the efficiency of energy deposited as protein in both the empty body and carcass compared with steers not receiving SbV. Efficiency of energy deposited as protein in the empty body tended to be greater (P < .10) for SYN-implanted steers than for steers not implanted. The efficiency with which total feed energy was deposited as protein in empty body was 10% greater for the SYN group than for the CTL group, 21% greater for the SbV group than for the CTL group, and 37% greater for the combined SYN + SbV treatment than for the CTL group. The data from this study are interpreted to indicate that SYN and SbV act in an additive manner to improve growth and protein deposition in young growing steers.

Animals↗

PubMed1995

Comparison of growth hormone-releasing factor and somatotropin: thyroid status of lactating, primiparous cows.

Effects of recombinant bovine growth hormone-releasing factor and recombinant bST on thyroxine 5'-deiodinase activities of liver and mammary gland were studied for lactating cows. Beginning on d 118 of lactation, 30 primiparous Holsteins received continuous infusions of 12 mg/d of releasing factor or 29 mg/d of bST or served as uninfused controls for 63 d. Blood samples were collected on d 1, 29, and 57, and samples of whole milk were collected at the early afternoon milking on d -5, 30, and 58. Liver and mammary tissue samples were obtained at slaughter on d 63. Infusion of releasing factor and bST decreased serum concentration of triiodothyronine by 10% and the ratio of triiodothyronine to thyroxine in serum by 20%. Concentrations of circulating triiodothyronine reflected a 30% decrease in hepatic 5'-deiodinase activity in response to infusion with releasing factor and bST. In contrast, treatment with releasing factor and bST did not affect 5'-deiodinase activity in the mammary gland and did not alter triiodothyronine concentration in milk. Data suggest that releasing factor and bST increase the hypothyroid status of the lactating cow and maintain an euthyroid condition in the mammary gland, thus enhancing the metabolic priority of the mammary gland.

Animals↗

PubMed1994

Circadian and ultradian rhythms of plasma thyroid hormone concentrations in lactating dairy cows.

Circadian and ultradian rhythms of thyroxine and triiodothyronine were analyzed by radioimmunoassay on integrated 15-min blood samples collected for 48 h from six lactating dairy cows. Body temperatures were recorded every 1.4 min using radiotelemetry. The cows were housed in an environmental chamber at 19.0 +/- 0.5 degrees C (lights on between 0700 and 2300 h), fed daily at 0900 h, and milked at 0800 and 2000 h. Mean concentrations of plasma triiodothyronine and thyroxine exhibited similar circadian rhythms with minima (0500-1300 h) and maxima (1700-0200 h) separated by 12 h. Triiodothyronine peaked 2 h before thyroxine. The thyroxine circadian rhythm preceded a circadian body temperature rhythm by 2 h. Superimposed on the circadian rhythm was an ultradian rhythm with a 90-min period that was 15-20% of the mean thyroid hormone concentrations. Peak thyroxine and triiodothyronine concentrations were 50 +/- 2 and 1.58 +/- 0.17 ng/ml, and minimal concentrations were 42 +/- 2 and 0.94 +/- 0.17 ng/ml, respectively. Our data indicate that peripheral triiodothyronine is regulated independently of peripheral thyroxine concentration.

Activity Cycles↗

PubMed1994

Tissue distribution and regulation of 5'-deiodinase processes in lactating rats.

Thyroxine 5'-deiodinase (5'D) catalyses deiodination of the prohormone thyroxine (T4) to the metabolically active hormone 3,5,3'-tri-iodothyronine (T3). Previously, it has been demonstrated that rat mammary gland expresses a 5'D with enzymatic properties equivalent to those of the type I enzyme (5'D-I) found in rat liver and kidney. Using complementary DNA (cDNA) for rat hepatic 5'D-I, we have examined expression of 5'D-I messenger RNA (mRNA) in liver, and mammary gland from virgin and lactating rats, and in seven other tissues from virgin rats. 5'D-I mRNA could not be detected in mammary gland either by Northern blotting or by the more sensitive technique of reverse transcribing mRNA and then amplifying the cDNA by polymerase chain reaction (RT-PCR). Analysis of the seven tissues from virgin rats by RT-PCR showed 5'D-I amplicons in liver, kidney and thyroid. No amplicons were detected in adrenal gland, cardiac muscle, skeletal muscle or spleen. In addition, the effect of lactation intensity on circulating thyroid hormones, hepatic and mammary gland 5'D activity, and hepatic 5'D-I mRNA levels was examined. A strong inverse relationship was noted between increased lactation intensity (suckling burden) and circulating T4 and T3, hepatic 5'D-I activity and hepatic 5'D-I mRNA levels. Mammary gland 5'D activity was positively correlated to lactation intensity. The data presented strongly suggest that the 5'D activity expressed in lactating mammary gland is encoded by a mRNA different from the 5'D-I message found in rat liver, kidney and thyroid gland, and may help explain the differential regulation of 5'D-I activity in these organs during lactation. In addition, hepatic 5'D-I activity was found to be correlated with the concentration of 5'D-I mRNA, suggesting that regulation is pretranslational. Results are consistent with a previously suggested involvement of 5'D in establishing metabolic adaptations to support lactation.

Animals↗

PubMed1994

The effects of high-forage diets with added palm oil on performance, plasma lipids, and carcass characteristics of ram lambs with initially high or low plasma cholesterol.

The objectives of this study were to examine the interaction between added palm oil in high-forage diets and initial concentration of plasma cholesterol on performance, plasma lipids, and carcass characteristics of growing ram lambs. Thirty-two Hampshire-Suffolk ram lambs (initial BW = 34.4 kg) were assigned to a 2 x 2 factorial design consisting of diet (basal [NPO] or 10.7% added palm oil [PO]) and initial plasma cholesterol concentration (high mean = 50 mg/dL [HC] or low mean = 38 mg/dL [LC]; SEM = 2; P = .01). The lambs were individually fed diets (77% forage-23% concentrate) that contained 16.0% CP, 2.14 Mcal of ME/kg (NPO), and 2.62 Mcal of ME/kg (PO). Metabolizable energy intakes were adjusted to .20 Mcal/kg of BW.75 for both dietary treatments. Lambs were weighed and feed intakes adjusted weekly. Lambs were bled via jugular venipuncture on d 28, 56, and 84 and lambs were slaughtered after they had been fed the diets for 90 d. Plasma concentrations of total cholesterol, high-density lipoprotein cholesterol, triglycerides, and nonesterified fatty acids were increased (P = .01) by feeding PO. Lambs fed PO were fatter than lambs fed NPO, as indicated by greater subcutaneous fat thickness and kidney and pelvic fat. Initial plasma cholesterol concentration had little effect on any of the parameters measured. Lambs fed PO had fatter carcasses than lambs fed NPO at calculated equalized ME intakes, which indicates that energy deposition is more efficient in palm oil-supplemented diets.

Animal Feed↗

PubMed1993

Relationships between the thyroid and somatotropic axes in steers. II: Effects of thyroid status on plasma concentrations of insulin-like growth factor I (IGF-I) and the IGF-I response to growth hormone.

Three studies assessed the effect of thyroid status on regulation of plasma IGF-I in cattle. First, four Angus-Hereford steers (av wt 345 kg) were fed 4 mg/d propylthiouracil daily for 35 d. With continued feeding of PTU steers were sequentially injected with thyroxine (T4, 5 mg/d, IM for 5 d) followed by triiodothyronine (T3, 2 mg/d, IM for 5 d). An injection of bovine pituitary growth hormone (GH, 0.1 mg/kg, IM) was given to each steer on day 35 of PTU, day 5 of T4 and again on day 5 of T3. PTU alone increased plasma thyroid stimulating hormone (TSH), decreased plasma T4 and T3 but had no influence on IGF-I. T3, but not T4, lowered plasma TSH, IGF-I and the IGF-I response to GH (P < .05). Next, twelve bull calves (av wht 167 kg) were divided equally into two groups. A control group was injected daily for five d with buffered saline; the experimental group was concurrently treated with T3 (5 mg/d, sc) for five d. Beginning the sixth day, all calves were injected with GH (0.1 mg/kg, IM daily) for three d with the respective buffer or T3 treatments continuing. Plasma IGF-I was depressed 29% by T3. The incremental area under the three-d response curve was less (P < .03) in T3 cattle. A growth trial was conducted in which twenty-four Angus x Hereford steers were injected daily with T3 (2 mg/kg, bi-daily x 56 d) or implanted with Synovex-S (S) in a 2 x 2 factorial arrangement. Synovex increased empty body protein gain (EBPG) and plasma IGF-I 15.5 and 27.9% (P < .01), respectively; T3 decreased EBPG and plasma IGF-I 13.9 and 15.1% (P < .07), respectively, in steers which maintained suppression in plasma TSH. The data support the conclusion that elevated T3 decreases plasma IGF-I, in part, through a diminished GH-responsiveness and anabolic treatments such as S can reverse the effects of excess T3.

Animals↗

PubMed1993

[Effects of inadequate cementing techniques on mechanical loading of bone cement].

Good, painfree and durable function of an endoprosthesis is highly dependent on its anchorage in the bony bed. Apart from the problem of mechanical loading of the prosthesis and the change in the strains in the cortical bone, stresses on the bone cement as a force-transmitting element, are of considerable importance. Inadequate cementing technique and resulting faulty cementing is a common cause of loosening of the endoprosthesis. The present article investigates the influence of inadequate cementing technique on the stress and strain conditions of bone cement, in particular at the distal end of the prosthesis.

Biomechanical Phenomena↗

PubMed1993

The effect of trenbolone acetate on performance, plasma lipids, and carcass characteristics of growing ram and ewe lambs.

The purpose of the study was to determine the effect of trenbolone acetate (TBA) on performance, plasma lipid metabolites, and carcass characteristics of growing ram and ewe lambs in two separate experiments. Treatments consisted of 1) a control, no implants, and 2) a TBA implant (60 mg of Finaplix; Hoechst-Roussel Agri-Vet). Twelve Rambouillet cross ram lambs (average 19.9 kg BW; Exp. 1) and 18 Suffolk-Hampshire ewe lambs (average 37.2 kg BW; Exp. 2) were given ad libitum access to a 77% forage/23% concentrate diet (15.5% CP and 2.14 Mcal of ME/kg). On d 0, six rams and nine ewes received TBA as an ear implant and six rams and nine ewes were designated as controls. Blood samples were collected via jugular venipuncture on d 0, 28, 56, and 84 and plasma was separated and analyzed for lipid metabolites. Rams (30.5 kg BW) and ewes (50.0 kg BW) were slaughtered after 93 and 91 d, respectively. Average daily gain was not affected by TBA in rams (117 g/d) or ewes (159 g/d). Nutrient intake restricted normal BW gains in the rams. Plasma concentrations of total cholesterol, high-density lipoprotein cholesterol, triglycerides, and nonesterified fatty acids were not affected by TBA in either rams or ewes. Trenbolone acetate had no effect on subcutaneous fat measurements in either rams or ewes. Lamb chops from rams implanted with TBA were less (P < .04) tender (5.58 vs 4.26 kg/1.27-cm core) than lamb chops from control rams. Additional studies examining growth and carcass composition are needed in ruminants implanted with anabolic steroids and fed high-forage diets.

Adipose Tissue↗

PubMed1993

Effects of high-forage diets with added palm oil on performance, plasma lipids, and carcass characteristics of ram and ewe lambs.

The objectives of this study were to determine the effects of high-forage diets with and without added dietary palm oil (high in palmitic acid) fed at equalized ME intakes on performance, plasma lipids, and carcass characteristics of growing ram and ewe lambs. Thirty-one Hampshire or Suffolk lambs (35.7 kg BW) were used in a 2 x 2 factorial arrangement of the following treatments: 1) rams, no palm oil (R-NPO); 2) ewes, no palm oil (E-NPO); 3) rams, 10.7% dietary palm oil (R-PO); and 4) ewes, 10.7% dietary palm oil (E-PO). Both diets consisted of 77% forage and 23% concentrate. Diet DM contained 15.0% CP and 2.14 Mcal of ME/kg (NPO) or 2.62 Mcal of ME/kg (PO). Lambs were fed individually specified amounts of diet based on BW to equalize ME intake (.20 Mcal of ME/kg of BW.75) for both dietary treatments. Lambs were weighed and feed intakes were adjusted weekly. Lambs were bled by jugular venipuncture on d 28, 56, and 84 and were slaughtered after they had been fed the diets for 90 d. Lambs fed PO had greater (P < .01) ADG and efficiency (ADG/ME intake) than lambs fed NPO. Plasma concentrations of cholesterol, high-density lipoprotein cholesterol, triglycerides, and nonesterified fatty acids were increased (P < .01) by feeding PO. Lambs fed PO were fatter than lambs fed NPO, as evidenced by greater subcutaneous fat thickness and kidney and pelvic fat. Ewes had greater (P < .01) subcutaneous fat than did rams.(ABSTRACT TRUNCATED AT 250 WORDS)

Animal Feed↗

PubMed1993

Circadian and ultradian rhythms of peripheral cortisol concentrations in lactating dairy cows.

To investigate possible circadian and ultradian periodicities for plasma cortisol in lactating dairy cows, integrated 15-min blood samples taken sequentially over 48 h from six cows were analyzed by radioimmunoassay. The cows were housed in an environmental chamber at about 19 degrees C, 50% relative humidity, and 16 h of light and 8 h of darkness (lights on at 0700 h); fed daily at 0900 h; and milked at 0830 and 2000 h. Peripheral concentrations of cortisol for all six cows exhibited weak circadian rhythms--average minima were 3.1 ng/ml at 1800 h, maxima were 4.5 ng/ml at 0530 h--and strong ultradian rhythms with periods around 120 min. Peak to trough amplitudes of ultradian rhythms, 1 to 17 ng/ml, varied among and within cows over time. No direct relation between ultradian peaks and milking or feeding was apparent. Spectral analysis indicated that most power (variation) was centered around 1 cycle every 2 h, i.e., around a period of 120 min. This very strong, easily observable, ultradian rhythm indicates that an oscillation with a period around 120 min is probably intrinsic to mechanisms regulating peripheral glucocorticoid concentrations.

Activity Cycles↗

PubMed1993

Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations.

Neutron capture therapy has a promising role in cancer treatment since it can achieve selectivity at the cellular level. The effect of this therapy depends on the subcellular localization of boron atoms in the target cell. Five boron compounds were investigated in this study: the monomeric and dimeric sulfhydryl boranes (BSH and BSSB), a boronated phenylalanine (BPA), and two porphyrin complexes (BOPP and VCDP). The study shows that when exponentially growing rat 9L gliosarcoma cells are exposed to an isoeffective concentration of each of the five compounds for 1 h, BOPP produces a much higher intracellular level of boron than the other four compounds; BSSB produces the second highest level, while exposure to BSH, VCDP, and BPA resulted in lower intracellular boron levels. Subcellular fractionation studies showed that most of the boron localized in the cytoplasm of the cells with all five compounds. A significantly higher boron concentration was found in the lysosomes of the cells, but the nuclei contained only minimal concentrations of boron. Computer simulations of neutron capture reactions with boron using a Monte Carlo simulation code indicated that BOPP would yield the highest potential effectiveness, followed by BSSB, BSH, VCDP, and BPA, in that order.

Animals↗

PubMed1992

Transformation of rodent fibroblasts by herpes simplex virus: presence of morphological transforming region 1 (MTR 1) is not required for the maintenance of the transformed state.

Studies on the mechanisms of transformation of mammalian cells by herpes simplex virus (HSV) in vitro have been prevented so far by the extremely low transformation frequencies obtained in monolayer culture. Here we present a transformation system that relies on the direct seeding in soft agar of infected single cells, thus avoiding negative interactions between normal and transformed cells. We took advantage of HSV-I temperature-sensitive mutants at the UL9 locus, which codes for a DNA-binding protein necessary for viral DNA replication. At the non-permissive temperature, viral DNA synthesis and late gene expression are prevented. Viral gene expression is restricted to immediate early and early genes. Induction of transformation was highly efficient in our one-step transformation system. It depended on intact viral particles and viral DNA. Immediate early and/or early viral gene expression was sufficient to induce transformation. Colonies were stably transformed and did not show any rescue of viable virus after temperature downshift and co-cultivation with susceptible cells. Transformed cells maintained the transformed state in the absence of viral DNA. Our data therefore support the "hit-and-run" hypothesis for the transforming effect of HSV.

Animals↗

PubMed1992

Influence of thyroid status regulation and Synovex-S implants on growth performance and tissue gain in beef steers.

The separate and combined effects of Synovex-S (SYN) ear implants and thyroxine (T4)-5'-monodeiodinase inhibition (Trial 1) and T3 injection to create a mild elevation in circulating T3 concentrations (Trial 2) on BW gain and composition of gain were studied. Trial 1 used 24, 285-kg Angus steers in two experimental phases. Low-level feeding of propylthiouracil (PTU, 1.5 mg/kg BW daily) was used to achieve inhibition of T4-5'-monodeiodinase activity (TMA). Twelve steers received neither treatment (control) and 12 received SYN+PTU (hypothesized to maximize weight gain) from 0 to 56 d (phase 1) in a single factor treatment comparison. Subsequently, PTU was fed to six control steers and not fed to six of the original SYN+PTU steers from 56 to 175 d (phase 2) in a 2 x 2 arrangement of treatments. Trial 2 used 24, 302-kg Angus-Hereford steers. Treatments were without or with SYN and without or with sc injections of T3 in polyethylene glycol (2 micrograms/kg BW every 48 hr) in a 2 x 2 factorial arrangement of treatments. In both trials, all steers were individually fed a diet of a corn-based concentrate and silage mixture at an equal metabolizable energy intakes per unit of metabolic body weight (.25 Mcal/kg BW.75). Measurements of daily dry matter intakes, weekly BW, 28-d estimates of empty body components (measured by urea dilution), final TMA (trial 1) and plasma thyroid hormone concentrations were obtained. In both trials, SYN increased BW gain and protein accretion.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

PubMed1992

Plasma concentrations of thyroid hormone in steers treated with Synovex-S and 3,5,3'-triiodothyronine.

This experiment examined the effect of daily administration of 3,5,3'-triiodothyronine (T3) on plasma profiles of T3, thyroxine (T4), 3,3',5'-triiodothyronine (reverse T3; rT3) and thyrotropin (TSH) in beef steers in which protein accretion was increased by using implants of Synovex-S (SYN). Twenty-four Angus-Hereford steers (302 +/- 16 kg) were individually fed a diet of a corn-based concentrate and silage mixture for 56 d at equal energy intake per steer (ME/unit BW.75). A 2 x 2 factorial arrangement of treatments was used in which treatments were SYN ear implants (200 mg of progesterone and 20 mg of estradiol benzoate) or no implants and s.c. injections of T3 in polyethylene glycol (2 micrograms of T3/kg BW every 48 h) or no injections of T3. Blood samples were collected every 2 wk. Plasma T3 concentration during the experimental period was increased in T3-treated steers (3.0 +/- .1 vs 2.2 +/- .1 ng/mL, P < .01) and was decreased in SYN-implanted steers (2.4 +/- .1 vs 2.7 +/- .1 ng/mL, P < .01). Plasma T4 and rT3 concentrations were reduced (22 +/- 4 vs 75 +/- 2 and .04 +/- .01 vs .12 +/- .01 ng/mL, respectively, P < .01) in T3-treated steers. Concurrently, plasma TSH concentration was decreased in T3-treated steers (.37 +/- .01 vs .51 +/- .02 ng/mL, P < .02). Synovex-S increased BW gain (21.0%, P < .01) and protein gain (35.6%, P < .01) compared with that of nonimplanted steers. Body weight gain and protein gain were not affected by treatment with T3.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

PubMed1992

Effects of dietary canola seed and soy lecithin in high-forage diets on cholesterol content and fatty acid composition of carcass tissues of growing ram lambs.

Phospholipids (soy lecithin) are important in the emulsification of lipids and may escape the rumen and influence the absorption of fatty acids in the small intestine. Our objectives were to determine the influence of dietary canola seed (high in unsaturated fatty acids) and soy lecithin in high-forage diets on total lipid content, cholesterol content, and fatty acid composition of carcass tissues. Forty-three Hampshire or Suffolk-sired ram lambs were weaned at 60 d of age (average 23.6 kg of BW) and assigned to a 2 x 2 factorial arrangement of treatments consisting of 1) basal diet (control = BAS), 2) BAS with 6% whole canola seed (CS), 3) BAS with 4.9% deoiled soy lecithin (SL), and 4) BAS with 6% CS and 4.8% SL (CSSL). The BAS diet consisted of 70% forage and 30% concentrate and contained 15% CP and 2.2 Mcal of ME/kg. Lambs were individually fed and given ad libitum access to feed to an average final BW of 52.1 kg. Longissimus muscle (LM) from the left side of each carcass posterior to the 13th rib (12 to 15 cm in length) was excised and the lean (LM) and corresponding subcutaneous (s.c.) adipose tissue were separated, frozen, and later used for lipid analysis by gas-liquid chromatography. In lean tissue, feeding lambs CS reduced (P less than .01) the proportion of total polyunsaturated fatty acids (PUFA) and feeding SL increased (P less than .01) the proportion of total PUFA. In s.c. adipose tissue, lambs fed CS had lower (P less than .01) saturated fatty acids (SFA) and lambs fed SL had increased (P less than .03) PUFA.(ABSTRACT TRUNCATED AT 250 WORDS)

Adipose Tissue↗